Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus

Although rare, atypical hemolytic syndrome (aHUS) has been recognized as one of the direst complications of systemic lupus erythematosus (SLE). Furthermore, the diagnosis of coexisting aHUS and SLE is a diagnostic dilemma with similar clinical characteristics between both entities. Eculizumab is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhamoud, Issa, Freiberg, Sydney A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205680/
https://www.ncbi.nlm.nih.gov/pubmed/35733457
http://dx.doi.org/10.7759/cureus.25117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205680/
https://www.ncbi.nlm.nih.gov/pubmed/35733457
http://dx.doi.org/10.7759/cureus.25117

Ejemplares similares